C&R Research Inc.

As of June 30, 2026, C&R Research Inc. carries a market capitalization of 22.68B, placing it among publicly traded companies globally. Its enterprise value stands at 19.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, C&R Research Inc. has 11.49M shares outstanding.

As of June 30, 2026, C&R Research Inc. trades at a trailing price-to-earnings ratio of 15.16. The price-to-sales ratio is 0.40, and the price-to-book ratio stands at 0.46.

As of June 30, 2026, C&R Research Inc. trades at an EV/EBITDA multiple of 27.80 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 19.92B versus a market cap of 22.68B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, C&R Research Inc. maintains a current ratio of 1.06, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.08, indicating elevated leverage, while an interest coverage ratio of 2.33 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, C&R Research Inc. posted a return on equity (ROE) of 3.42, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 1.89, measuring how efficiently the asset base is converted into earnings. The company generates approximately 121.97M in revenue per employee across its workforce of 521.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, C&R Research Inc. recorded 213.13M in income tax expense. The company reported a pretax loss of -830.05M and 1.66B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, C&R Research Inc.'s stock has declined approximately 52.74% over the past 52 weeks. The 50-day moving average sits at 2,131.54, while the 200-day moving average is 3,349.80.

Over the twelve months ended June 30, 2026, C&R Research Inc. generated 63.55B in revenue and converted that into 1.66B in net income, yielding earnings per share of -81.67. EBITDA reached 716.38M, while operating income came in at -459.54M.

As of June 30, 2026, C&R Research Inc. holds 15.48B in cash and equivalents against 15.80B in total debt, resulting in a net debt position of 1.56B. Total book value stands at 49.44B, with working capital of 2.51B providing operational flexibility.

C&R Research Inc. produced -3.39B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -273.47M in capital expenditures, free cash flow totaled -3.66B - equivalent to -286.62 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -0.72 and net profit margin of 2.62 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, C&R Research Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -14.53: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -37.85, meaning C&R Research Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

C&R Research Inc.'s most recent stock split took place on June 30, 2026 with a 5:1 split ratio.

As of June 30, 2026, C&R Research Inc. has an Altman Z-Score of 1.12, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.